<DOC>
	<DOC>NCT00288639</DOC>
	<brief_summary>The objective of study is to assess the clinical improvement (change in seizure frequency), safety, and tolerability of subjects with partial seizures following adjunctive therapy of pregabalin BID (150 to 600 mg/day titration) in addition to existing standards AEDs.</brief_summary>
	<brief_title>Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Outpatients equal to or greater than 18 years of age with diagnosis of epilepsy with partial seizures having minimum of two partial seizures during a two month period before the baseline visit Having a clinical history of epilepsy and AED treatment at least 1 year prior to inclusion AED or Seizures/Epilepsy Related Exclusions:having a treatable cause of seizures Having absences seizures Having had status epileptics within the year prior to inclusion Having a progressive neurological or systematic disorder Having known significant renal or hepatic dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Pregabalin for partial seizures</keyword>
</DOC>